Summary
Jeff Fisher's episode is split between a headlines comedy segment and a substantive interview with Dr. Rachna Patel, author of The CBD Oil Solution. Dr. Patel provides a clear medical perspective on CBD, explaining that it comes from the cannabis family of plants and can be derived from either hemp (less than 0.3% THC) or marijuana (more than 0.3% THC). She notes that certain conditions benefit from high CBD, others from high THC, and some from both. The interview includes a rapid-fire Q&A covering key practical questions: CBD can interact with other medications (particularly blood thinners), side effects are possible but generally mild, drug test results depend on the product type and state laws, CBD is not addictive, and pets can use CBD products. Dr. Patel makes an important distinction between THC and CBD for anxiety, explaining that THC impacts dopamine levels and can worsen anxiety and cause paranoia, while CBD impacts serotonin levels, which is what actually helps with anxiety. She also discusses the regulatory landscape following the 2018 Farm Bill, which legalized hemp cultivation but left CBD regulation to the FDA. Dr. Patel warns about isolate CBD oils that claim zero THC, noting they use chemical processes involving pentene and hexene that may introduce unwanted compounds. She advocates for full research access and emphasizes that the legal situation varies significantly by state, particularly regarding employment drug testing protections.
Key Points
- CBD can come from hemp (less than 0.3% THC) or marijuana; most commercial CBD is hemp-derived
- THC impacts dopamine and can worsen anxiety; CBD impacts serotonin and helps with anxiety
- CBD can interact with medications, particularly blood thinners, so physician consultation is important
- CBD is not addictive and side effects are generally mild
- The 2018 Farm Bill legalized hemp cultivation but left CBD regulation to the FDA
- Isolate CBD oils claiming zero THC may use chemical processes (pentene, hexene) that introduce unwanted compounds
- Drug testing implications vary by state; some states with legal medical marijuana have built-in employee protections
- Topical CBD works for localized pain while internal use is better for systemic conditions like MS spasticity
Key Moments
CBD helps with migraines, pain, anxiety, and insomnia
Dr. Rachna Patel explains that CBD oil works effectively for conditions including migraines, headaches, muscle pain, nerve pain, anxiety, and insomnia.
"And according to this, and according to Dr. Rachna Patel, CBD oil is the solution, thus the title of her book, The CBD Oil Solution."
CBD comes from hemp and has multiple delivery methods
CBD comes from the cannabis family but primarily from hemp with less than 0.3% THC. It can be taken as drops under the tongue, inhaled through vaporizing, applied topically, or ingested.
"Sure. So basically, CBD comes from the cannabis family of plants, and it can come from either marijuana or it can come from hemp. And the main difference between hemp and marijuana is in the amount of THC that's made."
CBD impacts serotonin while THC impacts dopamine for anxiety
Dr. Patel explains that CBD helps anxiety by impacting serotonin levels, while THC can actually worsen anxiety by affecting dopamine. This is why CBD is preferred over THC for treating anxiety and PTSD.
"THC impacts dopamine levels, whereas CBD impacts serotonin levels. And with anxiety, what you really want is help with serotonin."
2018 Farm Bill legalized hemp cultivation nationwide
The 2018 Farm Bill made hemp cultivation legal throughout the United States, but the regulatory status of CBD itself remains confusing due to conflicting FDA and DEA classifications.
"Yeah, so the 2018 Farm Bill made the cultivation of hemp legal throughout the United States. Now, what wasn't addressed was CBD, okay? And it was addressed, but basically they put it in the hands of the FDA."
